Featured Case Study | Strategy Consulting and Coalition Building
Creating a Cross-Sector Collaboration to Address Clinical and Regulatory Challenges for a Rare Disease
Developing new drugs for rare diseases can be particularly challenging because of the relatively small numbers of patients and limited disease awareness. To enable a patient advocacy group to more effectively raise awareness and address clinical trial readiness challenges, our team helped them form a cross-sector collaboration with biopharma partners. By facilitating consensus-building and strategic planning for this collaboration, we enabled more rapid identification of common challenges and development of new programs to address these challenges. These programs, which we continue to support, are making a tangible impact on disease awareness and clinical trial readiness across the US.